pharmaceuticals
Pfizer Boosts 2025 Profit Forecast: Discover How Cost Cuts and Stellar Quarterly Results Drive Growth
Pfizer recently raised its profit outlook for the year, pointing to strong performance and successful cost-cutting measures. The company now ... Read more
Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more
Breaking News: Vinay Prasad Leaves the FDA—What This Means for Public Health
Vinay Prasad, a key figure at the Food and Drug Administration (FDA), recently left his position amidst some heated discussions ... Read more
UnitedHealth Predicts Lower 2025 Earnings Amid Rising Medical Costs: What It Means for Insurers
UnitedHealth Group recently shared its outlook for 2025, and the news isn’t great. The company anticipates adjusted earnings of at ... Read more
FDA Resumes Approval of Sarepta Therapeutics’ Duchenne Therapy for Younger Patients: What You Need to Know
The FDA has made a significant announcement regarding Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy. Effective Monday, the agency ... Read more
UnitedHealth Collaborates with DOJ on Medicare Billing Practices Investigation: What You Need to Know
UnitedHealth Group is currently under investigation by the Justice Department regarding its Medicare billing practices. This comes as a significant ... Read more
Unlocking Lung Health: Exploring the Lung-Gut Connection with Dr. Neal Barnard – The Nutritional Path to Better Breathing
Nutrition plays a crucial role in our health, especially concerning our gut microbiome. This lively community of microbes aids in ... Read more
Sarepta Therapeutics’ Duchenne Therapy: What an FDA Official Says About Its Challenging Road to Market
Sarepta Therapeutics is facing tough challenges with its gene therapy for Duchenne muscular dystrophy, called Elevidys. This treatment is currently ... Read more
Breaking News: Sarepta Therapeutics Suspends Duchenne Gene Therapy Shipments—What This Means for Patients
Sarepta Therapeutics announced it will stop shipments of Elevidys, a gene therapy for Duchenne muscular dystrophy, following a request from ... Read more
Trump’s Bold Move: Upcoming 200% Tariff on Pharmaceuticals Could Impact Your Wallet!
President Donald Trump has recently announced plans to impose tariffs of up to 200% on pharmaceuticals imported into the U.S. ... Read more
